The HDL drug specialist Cerenis Therapeutics has appointed Dr John Paolini as its new chief medical officer. Dr Paolini will …
Fujifilm inks another biosimilars deal, an explosion rocks an Aurobindo plant, plus manufacturing updates from Teva, Bellwyck Packaging and Indian …
The US FDA has granted approval to BioMarin Pharmaceutical for a $60 million expansion of its manufacturing facility in Novato, …

Abbott will develop a diagnostic kit for GlaxoSmithKline’s new lung cancer drug candidate. This is an expansion of a …

Roche has officially opened a 250 million Swiss franc ($271m) R&D centre in Switzerland that will be used to develop …
European regulators have approved a licence extension for Bristol-Myers Squibb and AstraZeneca’s type II diabetes treatment Onglyza. The oral DPP-4 …
Catalent Pharma Solutions, Inc. announced the appointment of Jonathan Arnold as Vice President and General Manager – Sterile Technologies effective …
Healthcare comms agency Munro & Forster has won an industry award for its innovative World Spirometry Day Campaign for the …
Janssen and the NHS Confederation have established a new mental health social networking site. The service, which will be free …

The UK government has performed a U-turn on its HPV vaccine programme by favouring Sanofi and MSD’s Gardasil over GlaxoSmithKline’s …
Peter Theil has joined UCB as its new vice president and head of non-clinical development for the firm’s new medicines …

Pfizer will acquire skin specialist Excaliard Pharmaceuticals as the firm looks to further diversify its pipeline. Financial terms of the …
Shire has filed applications with the European and US regulators to produce its Gaucher disease drug Vpriv (velaglucerase alfa) at …
A Pfizer facility in Ireland has become the first pharmaceutical plant in the world to meet a tough new standard …

PfizerOf all the patent cliffs in pharma, Lipitor’s expiry represents the biggest. Pfizer is now staring over the precipice, with …
Regulatory authorities around the world are recalling cancer drugs manufactured by Boehringer Ingelheim’s Ben Venue Laboratories subsidiary after an inspection …
The NHS in England does not perform well on some patient outcomes for cancer, stroke and respiratory diseases given the …

NICE is recommending Pfizer and Bristol-Myers Squibb’s Eliquis for blood clots after surgery. Specifically, NICE has said that Eliquis (apixaban) …

RSA, the global life sciences executive search and interim management firm, has announced a series of new appointments. RSA Switzerland …
Despite the burgeoning interest in Adaptive Trial Design (ATD), an extremely powerful tool when used effectively in the appropriate circumstances, …